Immune system and ME/CFS – key facts
Whilst no definitive diagnostic test or biomarker has yet been identified for ME/CFS, research shows multiple biological abnormalities, with strong…
Researcher Circle
On the 15th of September, the second meeting of ME Research UK’s ‘Researcher Circle’ took place online. The Circle meets every…
Similar mechanisms of exercise limitation identified for ME/CFS and long COVID.
A small exploratory study has identified that skeletal muscle oxygen diffusion – an important process in the body which ensures…
Freedom of information request to the DHSC
Under the Freedom of Information Act (FOIA), a law which allows members of the public to ask to see information…
The Netherlands fund additional 7 ME/CFS Studies
The extent of the vision and investment into ME/CFS research in the Netherlands is continuing apace. The funding of two…
Natural killer cells, genes, and ME/CFS
Cytotoxicity is the ability of a cell to damage another cell. Natural killer (NK) cells use this ability to destroy…
Will metformin have a role in treating ME/CFS and long COVID?
A review published in ACS Pharmacology & Translational Science explored the potential role of first-line type 2 diabetes medication –…
AI in ME/CFS research – BioMapAI
The use of artificial intelligence (AI) has rapidly advanced in recent years, enhancing our ability to process large amounts of…
Cognitive impairments in ME/CFS and long COVID
“Individuals with ME/CFS, particularly those with long COVID, are especially prone to memory and concentration difficulties” finds a study looking…
No additional funds envisaged to implement ME/CFS Delivery Plan.
In a slew of recent parliamentary questions, further details are emerging on the government’s stance on funding the Delivery Plan…
